High Flow Nasal Cannula
OtherOxygen delivery through Heated Humidified High Flow Nasal Cannula
Other names: HFNC
NCT Number: NCT02913040
In this multi-centre randomized controlled trial the investigators compare the effect on dyspnoea severity of oxgen delivery through High Flow Nasal cannula with Low Flow Nasal Prongs in children < 2 years of age hospitalised for bronchiolitis with moderate-severe dyspnoea.
Looking for future studies?
Notify Me1 week–24 month
All sexes
Interventional
Not applicable
Isala Klinieken, Zwolle, Overijssel, Netherlands
In this multi-centre randomized controlled trial the investigators compare the effect on dyspnoea severity of oxgen delivery through High Flow Nasal Cannula with Low Flow Nasal Prongs in children < 2 years of age hospitalised for bronchiolitis with moderate-severe dyspnoea. The study will take place on the pediatric (Non intensive care) units of 5 different hospitals in the Netherlands.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oxygen delivery through Heated Humidified High Flow Nasal Cannula
Other names: HFNC
Oxygen delivery through Low Flow Nasal Prongs
Other names: LFNC
Time frame: 24 hours
Sustained reduction in PEWS >= 2 points within 24 hours (min 0- max 28 points)
Time frame: 24 hours
(FLACC: Face, Legs, Activity, Cry, Consolability, min 0- max 10 points)
Time frame: 5 days
need for tubefeeding and/or intravenous fluids
Time frame: 15 days
duration of hospitalisation in days
Time frame: 5 days
Princess Amalia Children's Clinic
Other
High Flow Nasal Cannula Therapy for Infants With Bronchiolitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06932341
Bronchial Diseases, Bronchiolitis
St. Petersburg, Florida, United States
View Trial DetailsNCT06016244
Bronchial Diseases, Bronchial Hyperreactivity
Haarlem, North Holland, Netherlands
View Trial DetailsNCT02824744
Bronchial Diseases, Bronchiolitis
Montpellier, France
View Trial DetailsNCT03298217
Bronchial Diseases, Bronchiolitis
Montpellier, France
View Trial Details